Skip to content

Arcturus Therapeutics

Public companyUS1 field

Website

Where it works

Technology
NanotechnologyCommercial mRNA company with LUNAR lipid-mediated delivery and self-amplifying mRNA.

Events

DateEvent
Feb 14, 2025EU approves KOSTAIVE, the first self-amplifying mRNA COVID-19 vaccinenewsroom.csl.com· Product· Nanotechnology
About
Source
newsroom.csl.com (official, added by seed)
First seen
Sep 25, 2026
Last seen
Sep 25, 2026
DateChange
Sep 25, 2026Arcturus TherapeuticsCompany in Nanotechnology: Joined a field, Commercial mRNA company with LUNAR lipid-mediated delivery and self-amplifying mRNA.
Sep 25, 2026Arcturus TherapeuticsCompany: Added

Frontier tech by email

Tuesdays, only in weeks with new milestones, rounds or stage changes in the fields tracked here.

Double opt-in. Unsubscribe any time.